AL 34662 (AL 34497) is primarily utilized in the field of ophthalmology as a potential therapeutic agent for treating glaucoma and ocular hypertension. It functions as a prostaglandin analog, which helps in reducing intraocular pressure by increasing the outflow of aqueous humor from the eye. This mechanism makes it a promising candidate for managing conditions that could otherwise lead to optic nerve damage and vision loss. Research and clinical trials are ongoing to evaluate its efficacy, safety, and potential advantages over existing treatments in this domain.